- Home
- MTEK vs EDSA Comparison
MTEK vs EDSA Comparison
Compare MTEK & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEK
- EDSA
- Stock Information
- Founded
- MTEK 2008
- EDSA 2015
- Country
- MTEK Israel
- EDSA Canada
- Employees
- MTEK N/A
- EDSA N/A
- Industry
- MTEK
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- MTEK
- EDSA Health Care
- Exchange
- MTEK Nasdaq
- EDSA Nasdaq
- Market Cap
- MTEK 24.0M
- EDSA 17.2M
- IPO Year
- MTEK 2022
- EDSA N/A
- Fundamental
- Price
- MTEK $3.07
- EDSA $2.40
- Analyst Decision
- MTEK
- EDSA Strong Buy
- Analyst Count
- MTEK 0
- EDSA 2
- Target Price
- MTEK N/A
- EDSA $13.00
- AVG Volume (30 Days)
- MTEK 92.9K
- EDSA 17.2K
- Earning Date
- MTEK 09-05-2025
- EDSA 08-08-2025
- Dividend Yield
- MTEK N/A
- EDSA N/A
- EPS Growth
- MTEK N/A
- EDSA N/A
- EPS
- MTEK N/A
- EDSA N/A
- Revenue
- MTEK $6,078,953.00
- EDSA N/A
- Revenue This Year
- MTEK N/A
- EDSA N/A
- Revenue Next Year
- MTEK N/A
- EDSA N/A
- P/E Ratio
- MTEK N/A
- EDSA N/A
- Revenue Growth
- MTEK 50.80
- EDSA N/A
- 52 Week Low
- MTEK $1.61
- EDSA $1.55
- 52 Week High
- MTEK $6.47
- EDSA $5.00
- Technical
- Relative Strength Index (RSI)
- MTEK 55.22
- EDSA 53.67
- Support Level
- MTEK $2.97
- EDSA $2.41
- Resistance Level
- MTEK $3.32
- EDSA $2.48
- Average True Range (ATR)
- MTEK 0.27
- EDSA 0.10
- MACD
- MTEK 0.05
- EDSA -0.01
- Stochastic Oscillator
- MTEK 66.31
- EDSA 48.28
About MTEK Maris-Tech Ltd.
Maris Tech Ltd is a business-to-business approach, or B2B provider of remote video, audio, telemetry acquisition, distribution, and sharing solutions and products, using high-end digital video, audio, and wireless communication technologies. It designs, develops, manufactures and commercially sells miniature intelligent video and audio surveillance and communication systems, which are offered as products and solutions for the professional as well as the civilian and home security markets.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.